Achieve Life Sciences Stock (NASDAQ:QUIT)
Previous Close
$6.78
52W Range
$2.62 - $8.64
50D Avg
$7.28
200D Avg
$5.67
Market Cap
$658.57M
Avg Vol (3M)
$1.42M
Beta
2.43
Div Yield
-
QUIT Company Profile
Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.